Leadership Overview
Servier has 6 executives leading key functions including strategy, operations, marketing, and research.
Driven by a commitment to patient well-being, Servier continuously innovates in pharmaceutical development, aiming to deliver life-changing treatments globally.
Driven by a commitment to patient well-being, Servier continuously innovates in pharmaceutical development, aiming to deliver life-changing treatments globally.
Leadership Roles at Servier
Ramadan Ashour - Driver for the CEO
Ramadan Ashour, the Driver for the CEO at Servier, ensures seamless transportation and logistical support for executive travel. This role directly facilitates the CEO's operational efficiency by managing all aspects of personal and professional transit. Ashour's responsibilities include coordinating schedules, maintaining vehicle readiness, and ensuring punctuality for critical meetings and engagements. This support is vital for the CEO's ability to focus on strategic initiatives and maintain a demanding schedule. Ramadan Ashour's dedication guarantees that executive mobility contributes positively to Servier's overall operational flow and strategic execution.
Pedro Crisanto - Chief Operating Officer, Research & Development (USA), Servier Pharmaceuticals
Pedro Crisanto, the Chief Operating Officer, Research & Development (USA), Servier Pharmaceuticals at Servier, directs the operational execution of critical research and development activities within the United States. This executive oversees the complex processes involved in testing and developing new medicinal products, ensuring alignment with Servier's global R&D strategy and regulatory compliance. Crisanto's leadership focuses on optimizing the efficiency of Servier's three research centers, driving innovation from concept to clinical trials. The Chief Operating Officer, Research & Development (USA) ensures that resources are effectively allocated to accelerate the creation of novel therapies. Pedro Crisanto's operational oversight is fundamental to advancing Servier's commitment to patient well-being through groundbreaking pharmaceutical advancements.
Varso Toppjian - Institutional President of Servier Do Brasil
Varso Toppjian, the Institutional President of Servier Do Brasil at Servier, leads the strategic direction and operational management of Servier's operations within Brazil. This executive is responsible for expanding the company's presence and impact in the South American market, ensuring the effective distribution and accessibility of Servier's pharmaceutical products. Toppjian drives business development initiatives, fosters relationships with local healthcare stakeholders, and ensures compliance with regional regulations. The Institutional President of Servier Do Brasil plays a crucial role in translating Servier's global mission into localized success. Varso Toppjian's leadership is instrumental in advancing patient access to innovative treatments throughout Brazil.
Antoine Anh - Chief of Staff
Antoine Anh, the Chief of Staff at Servier, orchestrates strategic initiatives and operational alignment across the organization. This leadership position involves managing cross-functional projects, enhancing internal communication, and ensuring the effective execution of the CEO's agenda. Anh drives operational efficiency by streamlining processes and fostering collaboration between departments, directly supporting Servier's mission of developing innovative pharmaceuticals. The Chief of Staff acts as a key liaison, translating high-level strategy into actionable plans and monitoring progress against organizational goals. Antoine Anh's role is critical in maintaining focus on research, development, and global market expansion, ensuring Servier's non-profit foundation objectives are met.
Andrey Khudentsov - Chief Marketing Officer, Bd & Manager
Andrey Khudentsov, the Chief Marketing Officer, Bd & Manager at Servier, spearheads the strategic marketing and business development initiatives for the company. This role is pivotal in shaping Servier's market presence and driving the commercialization of its pharmaceutical products globally. Khudentsov oversees the development and implementation of comprehensive marketing strategies, identifying new business opportunities and fostering key partnerships. The Chief Marketing Officer, Bd & Manager ensures that Servier's innovative medicinal products reach patients effectively, aligning marketing efforts with the company's research and manufacturing capabilities. Andrey Khudentsov's leadership is essential for expanding Servier's global reach and reinforcing its position as an independent pharmaceutical leader.
Xavier Pernee - Responsible Information & Publicity
Xavier Pernee, the Responsible Information & Publicity at Servier, manages the company's external communications and public relations efforts. This critical function ensures that Servier's mission, research advancements, and commitment to patient care are effectively communicated to stakeholders worldwide. Pernee oversees the dissemination of information regarding new medicinal products and the company's non-profit foundation governance. The Responsible Information & Publicity role is key to building and maintaining Servier's reputation as an independent and innovative pharmaceutical entity. Xavier Pernee's strategic communication ensures transparency and fosters trust with the public, healthcare professionals, and regulatory bodies, supporting Servier's global impact.
Explore Leadership Teams in Manufacturing
Zydus is a global pharmaceutical company headquartered in Ahmedabad, India. Founded in 1952, the company operates manufacturing sites and research facilities across multiple states in India as well as in the United States and Brazil. Zydus specializes in developing, manufacturing, and distributing pharmaceutical products with a significant global footprint. The company maintains a strong presence in regulated markets including the United States, Europe, Latin America, and South Africa, while also serving numerous emerging markets worldwide. Zydus offers a comprehensive portfolio of pharmaceutical products and services, supported by extensive research and development capabilities.
Company Leadership HW
AB
TS
Founded in 1974, Apotex is a proud Canadian, global pharmaceutical company that produces high-quality, affordable medicines (both generic and innovative pharmaceuticals) for patients around the world.
Company Leadership
RS
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of various therapeutics in the United States. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera cancers; and Iclusig, a kinase inhibitor to treat chronic myeloid leukemia and philadelphia-chromosome positive acute lymphoblastic leukemia.
Company Leadership
AB
SS

Grupo NC is a leading Brazilian pharmaceutical company with roots dating back to 2014 when it began as a small pharmacy in Santo André. Officially founded in 1964 with its first factory in São Bernardo do Campo, the company has grown to become one of the largest pharmaceutical industries in Brazil. Grupo NC operates with a dual business model serving both B2B and B2C markets, offering innovative healthcare solutions and pharmacy retail services. The company maintains a strong presence in South America, particularly Brazil, while also expanding into Asian markets. Grupo NC is committed to sustainable development, innovation in healthcare solutions, and excellence in all operational aspects. The company's core values emphasize continuous improvement, responsible innovation, and making a positive impact in the markets where they operate.
Company Leadership ND
DM